IL118219A - Antifungal compositions comprising terbinafine and an azole, their use in the preparation of a medicament and process for their preparation - Google Patents

Antifungal compositions comprising terbinafine and an azole, their use in the preparation of a medicament and process for their preparation

Info

Publication number
IL118219A
IL118219A IL11821996A IL11821996A IL118219A IL 118219 A IL118219 A IL 118219A IL 11821996 A IL11821996 A IL 11821996A IL 11821996 A IL11821996 A IL 11821996A IL 118219 A IL118219 A IL 118219A
Authority
IL
Israel
Prior art keywords
preparation
azole
pct
terbinafine
medicament
Prior art date
Application number
IL11821996A
Other languages
English (en)
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of IL118219A publication Critical patent/IL118219A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Materials For Medical Uses (AREA)
IL11821996A 1995-05-12 1996-05-10 Antifungal compositions comprising terbinafine and an azole, their use in the preparation of a medicament and process for their preparation IL118219A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9509631.9A GB9509631D0 (en) 1995-05-12 1995-05-12 Antifungal combination

Publications (1)

Publication Number Publication Date
IL118219A true IL118219A (en) 2001-08-26

Family

ID=10774361

Family Applications (2)

Application Number Title Priority Date Filing Date
IL11821996A IL118219A (en) 1995-05-12 1996-05-10 Antifungal compositions comprising terbinafine and an azole, their use in the preparation of a medicament and process for their preparation
IL11821995A IL118219A0 (en) 1995-05-12 1996-05-10 Antifungal compositions

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL11821995A IL118219A0 (en) 1995-05-12 1996-05-10 Antifungal compositions

Country Status (26)

Country Link
US (1) US5985906A (da)
EP (1) EP0824350B1 (da)
JP (1) JPH11504931A (da)
KR (1) KR100443535B1 (da)
CN (1) CN1100539C (da)
AT (1) ATE246504T1 (da)
AU (1) AU712914B2 (da)
CA (1) CA2219651C (da)
CY (1) CY2496B1 (da)
CZ (1) CZ291144B6 (da)
DE (1) DE69629367T2 (da)
DK (1) DK0824350T3 (da)
ES (1) ES2205042T3 (da)
FI (1) FI120079B (da)
GB (1) GB9509631D0 (da)
HK (1) HK1016064A1 (da)
HU (1) HU224920B1 (da)
IL (2) IL118219A (da)
MX (1) MX9708699A (da)
NO (1) NO317030B1 (da)
PL (1) PL322749A1 (da)
PT (1) PT824350E (da)
SK (1) SK150797A3 (da)
TW (1) TW464492B (da)
WO (1) WO1996035423A1 (da)
ZA (1) ZA963754B (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6187757B1 (en) 1995-06-07 2001-02-13 Ariad Pharmaceuticals, Inc. Regulation of biological events using novel compounds
US7067526B1 (en) 1999-08-24 2006-06-27 Ariad Gene Therapeutics, Inc. 28-epirapalogs
EP1212331B1 (en) * 1999-08-24 2004-04-21 Ariad Gene Therapeutics, Inc. 28-epirapalogs
GB0001315D0 (en) * 2000-01-20 2000-03-08 Novartis Ag Organic compounds
GB0003932D0 (en) * 2000-02-18 2000-04-12 Novartis Ag Pharmaceutical compositions
US6673373B2 (en) 2001-02-01 2004-01-06 Carlsbad Technology Inc. Antifungal formulation and the methods for manufacturing and using the same
US7244703B2 (en) 2001-06-22 2007-07-17 Bentley Pharmaceuticals, Inc. Pharmaceutical compositions and methods for peptide treatment
JP2006516548A (ja) 2002-12-30 2006-07-06 アンジオテック インターナショナル アクツィエン ゲゼルシャフト 迅速ゲル化ポリマー組成物からの薬物送達法
US7112561B2 (en) 2003-12-08 2006-09-26 Bentley Pharmaceuticals, Inc. Pharmaceutical compositions and methods for insulin treatment
US7740875B2 (en) * 2004-10-08 2010-06-22 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
US20060078580A1 (en) * 2004-10-08 2006-04-13 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
ES2368078T3 (es) 2005-04-07 2011-11-14 Toyama Chemical Co., Ltd. Composición farmacéutica y método que usa un agente antifúngico en combinación.
ATE538789T1 (de) 2006-10-06 2012-01-15 Toyama Chemical Co Ltd Pharmazeutische zusammensetzung mit einem phenylamidin-derivat und verfahren zur verwendung der pharmazeutischen zusammensetzung in kombination mit einem antimykotischen mittel
EP2121572A2 (en) * 2006-12-08 2009-11-25 Auspex Pharmaceuticals Inc. Preparation and utility of substituted allylamines
WO2009089549A1 (en) 2008-01-11 2009-07-16 Massachusetts Eye & Ear Infirmary Conditional-stop dimerizable caspase transgenic animals
CA2905229C (en) 2013-06-11 2023-10-10 Clontech Laboratories, Inc. Protein enriched microvesicles and methods of making and using the same

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4144346A (en) * 1977-01-31 1979-03-13 Janssen Pharmaceutica N.V. Novel 1-(1,3-dioxolan-2-ylmethyl)-1H-imidazoles
US4218458A (en) * 1978-06-23 1980-08-19 Janssen Pharmaceutica, N.V. Heterocyclic derivatives of (4-aryloxy-methyl-1,3-dioxolan-2-yl)methyl-1H-imidazoles and 1H-1,2,4-triazoles
GB2099818A (en) * 1981-06-06 1982-12-15 Pfizer Ltd Triazoles
US4782059A (en) * 1986-09-29 1988-11-01 Merck & Co., Inc. Method of controlling mycotic infections and compositions therefor
JP2581707B2 (ja) * 1987-10-02 1997-02-12 科研製薬株式会社 抗真菌剤組成物
CA2016738A1 (en) * 1989-06-08 1990-12-08 Philippe Guerry Substituted aminoalkylbenzene derivatives
JPH0338522A (ja) * 1989-07-05 1991-02-19 Maruho Kk 抗真菌性組成物
JPH0338521A (ja) * 1989-07-05 1991-02-19 Maruho Kk 抗真菌性組成物
CA2020888A1 (en) * 1989-07-27 1991-01-28 Philippe Guerry Substituted aminoalkoxybenzene derivatives
US5214046A (en) * 1989-07-27 1993-05-25 Hoffmann-La Roche Inc. Substituted aminoalkoxybenzene anti-fungicidal compositions and use
CA2044533A1 (en) * 1990-06-29 1991-12-30 Philippe Guerry Substituted aminoalkylbiphenyl derivatives
US5696164A (en) * 1994-12-22 1997-12-09 Johnson & Johnson Consumer Products, Inc. Antifungal treatment of nails
JP3038522U (ja) 1996-12-05 1997-06-20 秀俊 筬 カード型紙箱ポプリ
JP3038521U (ja) 1996-12-05 1997-06-20 啓次 小峰 排泄物一時保持具用の水溶繊維製ステック状吸液材

Also Published As

Publication number Publication date
CA2219651A1 (en) 1996-11-14
CA2219651C (en) 2007-03-27
NO975134D0 (no) 1997-11-07
KR19990014708A (ko) 1999-02-25
ES2205042T3 (es) 2004-05-01
AU712914B2 (en) 1999-11-18
WO1996035423A1 (en) 1996-11-14
US5985906A (en) 1999-11-16
FI973812A0 (fi) 1997-09-26
DE69629367T2 (de) 2004-06-09
IL118219A0 (en) 1996-09-12
CN1184427A (zh) 1998-06-10
KR100443535B1 (ko) 2004-12-17
ZA963754B (en) 1997-11-10
FI973812A (fi) 1997-11-11
ATE246504T1 (de) 2003-08-15
CN1100539C (zh) 2003-02-05
HUP9801140A2 (hu) 1999-01-28
EP0824350A1 (en) 1998-02-25
CZ291144B6 (cs) 2002-12-11
HU224920B1 (en) 2006-04-28
DE69629367D1 (de) 2003-09-11
MX9708699A (es) 1998-02-28
AU5818396A (en) 1996-11-29
FI120079B (fi) 2009-06-30
PT824350E (pt) 2003-12-31
HK1016064A1 (en) 1999-10-29
NO317030B1 (no) 2004-07-26
NO975134L (no) 1997-11-07
DK0824350T3 (da) 2003-11-03
JPH11504931A (ja) 1999-05-11
CZ354797A3 (cs) 1998-02-18
CY2496B1 (en) 2005-09-02
TW464492B (en) 2001-11-21
PL322749A1 (en) 1998-02-16
EP0824350B1 (en) 2003-08-06
HUP9801140A3 (en) 2000-07-28
GB9509631D0 (en) 1995-07-05
SK150797A3 (en) 1998-05-06

Similar Documents

Publication Publication Date Title
IL118219A (en) Antifungal compositions comprising terbinafine and an azole, their use in the preparation of a medicament and process for their preparation
LU93229I2 (fr) "pitolisant et ses sels pharmaceutiquement acceptables, tel que chlorhydrate"
SG49790A1 (en) Stabilised pharmaceutical
GR3035621T3 (en) New pyrimidone derivatives with antifungal activity
ES2185660T3 (es) Nuevo uso de dexmedetomidina.
PL324625A1 (en) Fungicidal compositions
HU9503625D0 (en) Use of p antagonist for producing pharmaceutical compositions for treating acne, rosacea and/or pubic arythema
IL152908A0 (en) USE OF (+)-a- (2,3-DIMETHOXYPHENYL)-1-[2-(4-FLUOROPHENYL) ETHYL] -4-PIPERIDINEMETHANOL OR ITS PRODRUG IN THE TREATMENT OF SYMPTOMS OF DEMENTIA AND DOPAMINE INDUCED PSYCHOSIS
GB0015246D0 (en) Method for the treatment of urinary incontinence
NZ241234A (en) Amino polyhydroxy cyclohexane derivatives and medicaments
DK1387837T3 (da) Hidtil ukendte azol- eller triazolderivater, fremgangsmåden til deres fremstilling og deres anvendelse som antimykotiske lægemidler
PL323305A1 (en) Applications of allyl amines
HUT77175A (hu) Szelegilin alkalmazása epilepsziás betegségek kezelésére használható gyógyszerkészítmények előállítására és szelegilint tartalmazó epilepsziaellenes gyógyszerkészítmények
HK1005651A1 (en) Use of forskolin or extracts containing it in the manufacture of a medicament for the treatment of alcohol addiction

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees